{"url_path":"/sec/ahco/8-k/2026-06-02/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain","topic":"sec","document":{"doc_type":"8-K/A","doc_date":"2026-06-02","source_url":"https://www.sec.gov/Archives/edgar/data/1725255/0001104659-26-069119-index.html","accession_number":"0001104659-26-069119","cik":"0001725255","ticker":"AHCO","issuer_name":"AdaptHealth Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1725255/0001104659-26-069119-index.html","primary_entity_key":"0001725255","primary_entity_name":"AdaptHealth Corp."},"word_count":398,"has_tables":true,"body_markdown":"**Item 5.02. Departure of Directors or Certain\nOfficers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**\n\n \n\nOn May 5, 2026, AdaptHealth Corp. (the “Company”)\nfiled a Current Report on Form 8-K (the “Original Filing”) reporting, among other things, the appointment of Daniel McFadden\nas Chief Operating Officer of the Company, effective as of May 4, 2026 (the “Appointment Date”). The Original Filing\ninadvertently reported the Date of Report (Date of earliest event reported) on the cover page as May 5, 2026, when it should have been\nreported as May 4, 2026. The Company is filing this Amendment No. 1 on Form 8-K/A (this “Amendment No. 1”) to (i) correct\nthe incorrect Date of Report on the Original Filing and (ii) provide additional information regarding material changes to Mr. McFadden’s\ncompensation that had not been determined at the time of the Original Filing. This Amendment No. 1 supplements the Original Filing and\nshould be read in conjunction with the Original Filing.\n\n \n\nOn May 27, 2026, in connection with Mr. McFadden’s\npromotion to Chief Operating Officer, the Compensation Committee of the Company’s Board of Directors (the “Committee”)\napproved an increase to Mr. McFadden’s annual base salary from $410,000 to $550,000, with retroactive effect to the Appointment\nDate. Mr. McFadden will continue to be eligible to receive an annual incentive bonus with a target amount equal to 100% of his increased\nbase salary. For the Company’s 2026 fiscal year, such target bonus amount and any actual bonus payable will be pro-rated based on\nthe actual base salary paid to Mr. McFadden in 2026. The Committee also approved a one-time grant of restricted stock units covering\na number of shares of the Company’s common stock with a value of $464,110 (determined in a manner consistent with the Company’s\nhistoric practices) pursuant to the Company’s Second Amended and Restated 2019 Stock Incentive Plan, 50% of which will vest in equal\ninstallments annually over three years and 50% of which will be eligible to vest between 0% and 200% based on the Company’s total\nshareholder return (“TSR”) relative to the TSRs of the Company’s peer companies over a three-year performance period\nbeginning on February 1, 2026, subject to Mr. McFadden’s continued employment with the Company.\n\n \n\nExcept as expressly stated herein, this Amendment\nNo. 1 does not amend or update any other information contained in the Original Filing, which remains unchanged."}